Last updated: 2026-09-16 12:18:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Quanterix Corporation (QTRX) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $2,72, with a market capitalisation of $118,23M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,15 to $8,77. This page covers its latest market performance, valuation, price trends and company information.
$118,23M | |
$2,70 | |
$92,57 | |
$2,15 | |
$2,72 | |
1,01K | |
907,93K | |
-- | |
$8,77 | |
$2,15 | |
-- | |
-- |
Quanterix Corporation (QTRX) is trading at $2,72 in pre-market trading as of 2026-09-16 12:10:00, up 0,11% ($0,00) from the previous close of $2,72
Pre-market trading shows how investors are pricing QTRX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Quanterix Corporation (QTRX) moved from $2,69 to $2,72, representing a gain of 1,23% ($0,03).
The stock traded between $2,37 and $2,83 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1,38 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 8,7%
QTRX is currently trading at $2,72, placing it 8,7% of the way from its 52-week low of $2,15 to its 52-week high of $8,77. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 450 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Quanterix Corporation (QTRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.